Psoriasis might increase the risk of certain cancers.
Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
The researchers found that patients with psoriasis had 1.53 times greater risk of developing a malignancy versus patients without psoriasis (P < 0.01). There were no significant differences in risk among patients receiving different treatments (topicals, phototherapy, systemics, or biologic agents). For patients who developed malignancy, survival did not differ among those with or without psoriasis.
“Patients with psoriasis may experience an elevated risk of melanoma and hematologic cancers, compared with the general population,” the authors write. “The risk is not increased by systemic or biologic psoriasis therapies.”
Read full article: Psoriasis may up risk of melanoma, hematologic cancer
 |
Read Full Article: Psoriasis may up risk of melanoma, hematologic cancer |
|---|
